Draconis Pharma was founded in October 2011 after the acquisition of the Drug Discovery unit from the biopharmaceutical company Palau Pharma S.A. This operation allowed Draconis Pharma to bring on board a team of experienced scientific staff and acquire cutting-edge technology in the area of drug discovery and preclinical development.